166 related articles for article (PubMed ID: 16284732)
1. Distribution of somatostatin in pancreatic ductal adenocarcinoma remodels the normal pattern of the protein during foetal pancreatic development: an immunohistochemical analysis.
Tamiolakis D; Simopoulos C; Venizelos J; Lambropoulou M; Nikolaidou S; Tsikouras P; Koutsougeras G; Alexiadis G; Menegaki M; Papadopoulos N
Clin Exp Med; 2005 Oct; 5(3):106-11. PubMed ID: 16284732
[TBL] [Abstract][Full Text] [Related]
2. Does neoplastic gastrin expression remodel the embryonal pattern of the protein? A study in human pancreas.
Tamiolakis D; Venizelos I; Simopoulos C; Kotini A; Jivannakis T; Papadopoulos N
Hepatogastroenterology; 2004; 51(55):249-52. PubMed ID: 15011877
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic-polypeptide in the human pancreas: expression and quantitative variation during development and in ductal adenocarcinoma.
Tamiolakis D; Simopoulos C; Kotini A; Venizelos I; Jivannakis T; Papadopoulos N
Acta Medica (Hradec Kralove); 2003; 46(1):9-14. PubMed ID: 12747533
[TBL] [Abstract][Full Text] [Related]
4. Does neoplastic cholecystokinin expression reflect the embryonal pattern of the protein? A study in human pancreas.
Tamiolakis D; Venizelos I; Simopoulos C; Lambropoulou M; Kotini A; Jivannakis T; Alexiadis G; Boglou P; Papadopoulos N
Acta Medica (Hradec Kralove); 2004; 47(2):101-5. PubMed ID: 15446358
[TBL] [Abstract][Full Text] [Related]
5. Analysis of c-kit protein expression in pancreatic neoplasms and its implication for prognosis.
Kimura W; Ma J; Takeshita A; Yamamoto T; Moriya T; Hirai I; Fuse A
Hepatogastroenterology; 2007 Dec; 54(80):2203-8. PubMed ID: 18265633
[TBL] [Abstract][Full Text] [Related]
6. Ductal cells of the pancreas.
Grapin-Botton A
Int J Biochem Cell Biol; 2005 Mar; 37(3):504-10. PubMed ID: 15618005
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas: an immunohistochemical study with surgical pathology correlation.
Giorgadze TA; Peterman H; Baloch ZW; Furth EE; Pasha T; Shiina N; Zhang PJ; Gupta PK
Cancer; 2006 Jun; 108(3):186-97. PubMed ID: 16628655
[TBL] [Abstract][Full Text] [Related]
8. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.
Liu H; Shi J; Anandan V; Wang HL; Diehl D; Blansfield J; Gerhard G; Lin F
Arch Pathol Lab Med; 2012 Jun; 136(6):601-9. PubMed ID: 22646265
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
Dancer J; Takei H; Ro JY; Lowery-Nordberg M
Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma.
Vizio B; Mauri FA; Prati A; Trivedi P; Giacobino A; Novarino A; Satolli MA; Ciuffreda L; Camandona M; Gasparri G; Bellone G
Oncol Rep; 2012 Jan; 27(1):69-76. PubMed ID: 21922151
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis.
Dittert DD; Kielisch C; Alldinger I; Zietz C; Meyer W; Dobrowolski F; Saeger HD; Baretton GB
Hum Pathol; 2008 Jul; 39(7):1002-10. PubMed ID: 18495213
[TBL] [Abstract][Full Text] [Related]
12. Podocalyxin-like protein 1 expression is useful to differentiate pancreatic ductal adenocarcinomas from adenocarcinomas of the biliary and gastrointestinal tracts.
Ney JT; Zhou H; Sipos B; Büttner R; Chen X; Klöppel G; Gütgemann I
Hum Pathol; 2007 Feb; 38(2):359-64. PubMed ID: 17137615
[TBL] [Abstract][Full Text] [Related]
13. Expression of intermediate filaments in normal and neoplastic exocrine pancreas.
Santini D; Ceccarelli C; Martinelli GN; Pasquinelli G; Leone O; Marrano D; Mancini AM
Zentralbl Pathol; 1994 Aug; 140(3):247-58. PubMed ID: 7524653
[TBL] [Abstract][Full Text] [Related]
14. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T; Shimamoto F; Hiyama E
J Surg Oncol; 2008 Apr; 97(5):469-75. PubMed ID: 18161862
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of epiplakin1 in pancreas, pancreatic cancer and regenerating pancreas.
Yoshida T; Shiraki N; Baba H; Goto M; Fujiwara S; Kume K; Kume S
Genes Cells; 2008 Jul; 13(7):667-78. PubMed ID: 18498355
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro.
Sipos B; Hahn D; Carceller A; Piulats J; Hedderich J; Kalthoff H; Goodman SL; Kosmahl M; Klöppel G
Histopathology; 2004 Sep; 45(3):226-36. PubMed ID: 15330800
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme-independent, local angiotensin II-generation in human pancreatic ductal cancer tissues.
Ohta T; Amaya K; Yi S; Kitagawa H; Kayahara M; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
Int J Oncol; 2003 Sep; 23(3):593-8. PubMed ID: 12888892
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
[TBL] [Abstract][Full Text] [Related]
19. Analyzing miRNAs in ductal adenocarcinomas of the pancreas.
Mees ST; Schleicher C; Mardin WA; Senninger N; Colombo-Benkmann M; Haier J
J Surg Res; 2011 Aug; 169(2):241-6. PubMed ID: 20080250
[TBL] [Abstract][Full Text] [Related]
20. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.
Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B
J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
